Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Measles
2024
2020
Europe
Clear all
Type of publications
NITAG documentation
(18)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(1)
Topics
Available to download in languages
Regions
Europe
(20)
Africa
(1)
Americas
(63)
South-East Asia
(1)
Western Pacific
(19)
Countries
Belgium
(1)
Denmark
(1)
France
(4)
Ireland
(1)
Netherlands
(1)
Sweden
(1)
United Kingdom
(9)
Diseases
COVID-19
(18)
Measles
(2)
Dengue
(1)
Ebola
(3)
Herpes zoster
(1)
Human papillomavirus (HPV)
(5)
Influenza
(5)
Pneumococcal disease
(2)
Tuberculosis
(1)
Typhoid
(1)
Varicella
(1)
Yellow fever
(1)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Target population
Adults
(1)
All age groups
(1)
Healthcare workers
(2)
Older adults
(1)
Parents/caregivers
(1)
Travellers
(1)
Publication date
2024
(2)
2020
(18)
2023
(15)
2022
(34)
2021
(76)
2019
(3)
2018
(3)
2017
(3)
2016
(2)
2015
(2)
2014
(1)
2013
(1)
2012
(1)
2011
(1)
2010
(4)
20 results found
2024
∙
JCVI
JCVI statement on COVID-19 vaccination in spring 2024 and considerations on future COVID-19 vaccination
2024
∙
NIAC
Updated recommendations for the vaccination of adults against measles
2020
∙
Wilder-Smith, A. B. Qureshi, K.
Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine
2020
∙
JCVI
Advice on priority groups for COVID-19 vaccination
2020
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Sars-Cov-2 vaccination strategy - Preliminary recommendations on the strategy for prioritizing populations to be vaccinated
2020
∙
JCVI
Advice on priority groups for COVID-19 vaccination
2020
∙
Ines Campos-Matos, Sema Mandal
Annex A: COVID-19 vaccine and health inequalities: considerations for prioritisation and implementation
2020
COVID-19 vaccination: BioNTech/Pfizer
2020
∙
Health Council of the Netherlands
Executive summary of the COVID-19 and vaccination against pneumococci (2)
2020
∙
JCVI
JCVI interim advice on priority groups for COVID-19 vaccination
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register